| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/0141-0229(94)90149-X |
| P698 | PubMed publication ID | 7764790 |
| P2093 | author name string | Jenkins N | |
| Curling EM | |||
| P433 | issue | 5 | |
| P921 | main subject | glycosylation | Q898365 |
| P304 | page(s) | 354-364 | |
| P577 | publication date | 1994-05-01 | |
| P1433 | published in | Enzyme and Microbial Technology | Q5381542 |
| P1476 | title | Glycosylation of recombinant proteins: problems and prospects | |
| P478 | volume | 16 |
| Q40884369 | A new Chinese hamster ovary cell line expressing alpha2,6-sialyltransferase used as universal host for the production of human-like sialylated recombinant glycoproteins. |
| Q39462326 | A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins. |
| Q40951866 | A two-dimensional protein map of Chinese hamster ovary cells |
| Q57713213 | Addition of Acetaldehyde to the N-Terminus of a Recombinant Schistosoma Mansoni Glutathione S-Transferase Upon High-Level Expression in Saccharomyces Cerevisiae |
| Q39859955 | An efficient platform for screening expression and crystallization of glycoproteins produced in human cells |
| Q30884937 | Analysis of glycoprotein heterogeneity by capillary electrophoresis and mass spectrometry |
| Q34167592 | Analysis of recombinat glycoproteins by mass spectrometry |
| Q64066671 | Bioproduction of the Recombinant Sweet Protein Thaumatin: Current State of the Art and Perspectives |
| Q41043557 | Blood proteins from transgenic animal bioreactors |
| Q40833139 | Butyrate increases production of human chimeric IgG in CHO-K1 cells whilst maintaining function and glycoform profile |
| Q37627225 | Carbohydrate analysis throughout the development of a protein therapeutic |
| Q40952878 | Chaperone and foldase coexpression in the baculovirus-insect cell expression system |
| Q42012779 | Chaperone-Assisted Soluble Expression of a Humanized Anti-EGFR ScFv Antibody in E. Coli. |
| Q53437158 | Characterization of adenosine receptor in its native environment: insights from molecular dynamics simulations of palmitoylated/glycosylated, membrane-integrated human A(2B) adenosine receptor. |
| Q43052323 | Characterization of site-specific O-glycan structures within the mucin-like domain of alpha-dystroglycan from human skeletal muscle |
| Q42615426 | Cloning of exoinulinase gene from Penicillium janthinellum strain B01 and its high-level expression in Pichia pastoris |
| Q43569961 | Comprehensive characterization of the site-specific N-glycosylation of wild-type and recombinant human lactoferrin expressed in the milk of transgenic cloned cattle |
| Q35845691 | DC-SIGN activation mediates the differential effects of SAP and CRP on the innate immune system and inhibits fibrosis in mice |
| Q38591154 | Development of M2BPGi: a novel fibrosis serum glyco-biomarker for chronic hepatitis/cirrhosis diagnostics |
| Q52603352 | Disruption of PMR1 in Kluyveromyces lactis improves secretion of calf prochymosin |
| Q47766012 | Dissolved oxygen concentration in serum-free continuous culture affects N-linked glycosylation of a monoclonal antibody. |
| Q46634886 | Effect of N-Acetylcystein on butyrate-treated Chinese hamster ovary cells to improve the production of recombinant human interferon-beta-1a |
| Q39172030 | Effect of culture pH on recombinant antibody production by a new human cell line, F2N78, grown in suspension at 33.0 °C and 37.0 °C. |
| Q41505038 | Effect of lipid supplements on the production and glycosylation of recombinant interferon-gamma expressed in CHO cells |
| Q41921972 | Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation |
| Q89553030 | Engineering Biology to Construct Microbial Chassis for the Production of Difficult-to-Express Proteins |
| Q73143449 | Engineering Chinese hamster ovary cells to maximize sialic acid content of recombinant glycoproteins |
| Q30873680 | Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans. |
| Q41873068 | Enhanced erythropoietin heterogeneity in a CHO culture is caused by proteolytic degradation and can be eliminated by a high glutamine level |
| Q50932279 | Enhanced sialylation of EPO by overexpression of UDP-GlcNAc 2-epimerase/ManAc kinase containing a sialuria mutation in CHO cells. |
| Q34309532 | Enhancement of recombinant human EPO production and glycosylation in serum-free suspension culture of CHO cells through expression and supplementation of 30Kc19. |
| Q40760951 | Expression of recombinant cytoplasmic yeast pyruvate carboxylase for the improvement of the production of human erythropoietin by recombinant BHK-21 cells |
| Q41240945 | Genetic engineering of α2,6-sialyltransferase in recombinant CHO cells and its effects on the sialylation of recombinant interferon-γ. |
| Q41176922 | Getting the glycosylation right: implications for the biotechnology industry |
| Q39857571 | Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin. |
| Q40942617 | Glycan structure and serum half-life of recombinant CTLA4Ig, an immunosuppressive agent, expressed in suspension-cultured rice cells with coexpression of human β1,4-galactosyltransferase and human CTLA4Ig. |
| Q73568466 | Glycosylation of polyclonal and paraprotein IgG in multiple myeloma |
| Q38126913 | Glycosylation: impact, control and improvement during therapeutic protein production. |
| Q39616628 | Improved bioprocess with CHO-hTSH cells on higher microcarrier concentration provides higher overall biomass and productivity for rhTSH. |
| Q59132146 | Improving Immunotherapy Through Glycodesign |
| Q55416256 | Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells. |
| Q107101726 | Isolation and Characterization of an Insect Cell Line Able to Perform Complex N-Linked Glycosylation on Recombinant Proteins |
| Q36730542 | Isolation and analysis of a baculovirus vector that supports recombinant glycoprotein sialylation by SfSWT-1 cells cultured in serum-free medium |
| Q38326531 | Metabolic effects on recombinant interferon-gamma glycosylation in continuous culture of Chinese hamster ovary cells |
| Q73616861 | Modification of a recombinant GPI-anchored metalloproteinase for secretion alters the protein glycosylation |
| Q41095950 | More than silk and honey--or, can insect cells serve in the production of therapeutic glycoproteins? |
| Q44671121 | N-glycan analysis by CGE-LIF: profiling influenza A virus hemagglutinin N-glycosylation during vaccine production |
| Q42048476 | N-glycan structures of human transferrin produced by Lymantria dispar (gypsy moth) cells using the LdMNPV expression system |
| Q30430759 | N-glycosylation of recombinant human interferon-gamma produced in different animal expression systems |
| Q47138416 | N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma |
| Q39622839 | Non-core region modulates interleukin-11 signaling activity: generation of agonist and antagonist variants. |
| Q39603349 | Novel baculovirus expression vectors that provide sialylation of recombinant glycoproteins in lepidopteran insect cells. |
| Q37323542 | Optimisation of the cellular metabolism of glycosylation for recombinant proteins produced by Mammalian cell systems |
| Q77665544 | Peptide capillary zone electrophoresis mass spectrometry of recombinant human erythropoietin: an evaluation of the analytical method |
| Q36279636 | Posttranslational processing of recombinant human interferon-gamma in animal expression systems |
| Q35962591 | Potency of Full-Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations |
| Q42050860 | Production of anti TNF-α antibodies in eukaryotic cells using different combinations of vectors carrying heavy and light chains |
| Q40937962 | Protein expression in mammalian and insect cell systems |
| Q32041385 | Quantitative analysis and process monitoring of site-specific glycosylation microheterogeneity in recombinant human interferon-gamma from Chinese hamster ovary cell culture by hydrophilic interaction chromatography. |
| Q40425278 | Recombinant glycoprotein production in the slime mould Dictyostelium discoideum |
| Q44525679 | Reduction of CMP-N-acetylneuraminic acid hydroxylase activity in engineered Chinese hamster ovary cells using an antisense-RNA strategy |
| Q36254504 | Related effects of cell adaptation to serum-free conditions on murine EPO production and glycosylation by CHO cells |
| Q41657395 | Separation used for purification of recombinant proteins |
| Q33807752 | Sialic acid linkage differentiation of glycopeptides using capillary electrophoresis - electrospray ionization - mass spectrometry |
| Q35137050 | Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. |
| Q36706838 | Structural determination of two N-linked glycans isolated from recombinant human lactoferrin expressed in BHK cells |
| Q43747464 | The effect of nitrogen source on yield and glycosylation of a human cystatin C mutant expressed in Pichia pastoris |
| Q41505044 | The effect of protein synthesis inhibitors on the glycosylation site occupancy of recombinant human prolactin |
| Q37106821 | The effects of culture conditions on the glycosylation of secreted human placental alkaline phosphatase produced in Chinese hamster ovary cells |
| Q36670313 | The impact of microcarrier culture optimization on the glycosylation profile of a monoclonal antibody |
| Q77798567 | Transgenic animal bioreactors in biotechnology and production of blood proteins |
| Q38947322 | What can mathematical modelling say about CHO metabolism and protein glycosylation? |
Search more.